bpc-157 fda status approval human studies safety warning Status: Is It Approved for Use? Is BPC‑157 a Risk? Safety, – BPC-157 just got voted in

Acknowledgements L.M

Regulatory status Injectable GHK-Cu is not FDA-approved for any condition

He first tried BPC-157 himself in 2013 (after a lower back injury, with positive results) and has been using it with patients for about eight years

doi: 10.3389/fnagi.2023.1204149 Received 11 April 2023 Accepted 14 August 2023 Published 05 September 2023 Volume 15 - 2023 Edited by Tao Wu, Tianjin University of Science and Technology, China Reviewed by Manish Kumar Tripathi, Hebrew University of Jerusalem, Israel Updates Copyright 2023 Eker, Bolat, Pekdemir, Duman and Karav

Drawbacks include dose-dependent adverse effects and the development of steroid resistance